pre-update Archives

Blog

Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara

Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…

CertaraMarch 10, 2023

On-Demand Webinar

What you should know about FDA Project Optimus for your oncology drug approval

Historically, the dosing strategy for oncology drugs has focused on the maximum tolerated dose. This…

CertaraMarch 10, 2023

On-Demand Webinar

RAPS Sponsored Webcast: Oops, I messed Up! How to Avoid (and Fix) Common Regulatory Submission Mistakes

Oops, I made a mistake! Everyone has made or seen one, and sometimes it is…

CertaraMarch 9, 2023

Press Release

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel…

CertaraMarch 7, 2023

Fact Sheet

GlobalSubmit™ eCTD Platform

GlobalSubmit enables teams to simplify the eCTD submission process to successfully publish, validate, and review…

CertaraMarch 3, 2023

Blog

Drug Development Considerations for Live Biotherapeutic Products

A new class of complex biologics has emerged in recent years. These are classified in…

CertaraMarch 3, 2023

Conference

ISMPP 2024

CertaraMarch 3, 2023

Press Coverage

Advancing data discovery in the life sciences through artificial intelligence

Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…

CertaraMarch 2, 2023

Video

Vyasa Demo

CertaraMarch 2, 2023

Press Release

Certara Announces Transition Plan For Chief Financial Officer

PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…

CertaraMarch 1, 2023

pre-update

Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara

What you should know about FDA Project Optimus for your oncology drug approval

RAPS Sponsored Webcast: Oops, I messed Up! How to Avoid (and Fix) Common Regulatory Submission Mistakes

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

GlobalSubmit™ eCTD Platform

Drug Development Considerations for Live Biotherapeutic Products

ISMPP 2024

Advancing data discovery in the life sciences through artificial intelligence

Vyasa Demo

Certara Announces Transition Plan For Chief Financial Officer

Newsletter sign up

Quick links

Solutions

Contact